GRACEcast Radiation Oncology Audio

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews the rationale and feasibility of using focal radiation in the setting of metastatic lung cancer.

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes new technologies that are improving the accuracy and safety of radiation for stage non-small cell lung cancer (NSCLC).

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, covers the benefits and limitations of stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC).

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews recent successful experiences with stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer and reviews several open questions about this strategy.

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes the ways to modulate the efficacy of radiation and explains why stereotactic body radiation therapy (SBRT) may be particularly effective for early lung cancer.

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, provides a historical perspective of radiation therapy as it transitions to a more targeted treatment approach.

The GRACEcast feeds on iTunes are moving!

This interview by medical oncologist Dr. Jack West of Dr. Vivek Mehta, radiation oncologist Seattle, includes discussion of emerging radiation techniques to treat medically inoperable early stage lung cancer, the challenges of treating locally advanced NSCLC with chemo/radiation, and the role of radiation in advanced lung cancer.

This interview by medical oncologist Dr. Jack West of radiation oncologist and lung cancer expert Dr. Vivek Mehta covers the current and emerging treatment options for radiation alternatives to treat early stage non-small cell lung cancer (NSCLC).